β-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping

Journal of Lipid Research

Volumn 49, Issue 9, 2008, Pages 1884-1893

  Lalazar, Gadi ^a   Ya'acov, Ami Ben ^a   Eliakim Raz, Noa ^a   Livovsky, Dan M ^a   Pappo, Orit ^a   Preston, Sarah ^a   Zolotarov, Lidya ^a   Ilan, Yaron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Lipid rafts; Liver tolerance; Natural killer T cell

Indexed keywords

BETA GALACTOSYLCERAMIDE; BETA GLUCOSYLCERAMIDE; BETA LACTOSYLCERAMIDE; CERAMIDE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; GANGLIOSIDE GM1; GLUCOSYLCERAMIDE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LACTOSYLCERAMIDE; MEMBRANE LIPID; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSPHINGOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CELL MEMBRANE; CELL SELECTION; COLITIS; CONTROLLED STUDY; DRUG RESPONSE; FLUORESCENCE MICROSCOPY; IMMUNOMODULATION; LIPID COMPOSITION; LIPID RAFT; LYMPHOCYTE COUNT; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SURVIVAL RATE; TH1 CELL; TH2 CELL; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LIVER; METABOLISM; NATURAL KILLER CELL; PATHOLOGY; PHYSIOLOGY; SPLEEN; T LYMPHOCYTE;

ANIMALS; CD4-CD8 RATIO; CD8-POSITIVE T-LYMPHOCYTES; COLITIS; CYTOKINES; GLYCOSPHINGOLIPIDS; KILLER CELLS, NATURAL; LIVER; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES; TRINITROBENZENESULFONIC ACID;

EID: 53149151479     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800113-JLR200     Document Type: Article

References (42)

1. Crispe, I. N., T. Dao, K. Klugewitz, W. Z. Mehal, and D. P. Metz. 2000. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol. Rev. 174: 47-62.
2. + T cells by the normal liver. J. Immunol. 163: 3202-3210.
3. Crispe, I. N., M. Giannandrea, I. Klein, B. John, B. Sampson, and S. Wuensch. 2006. Cellular and molecular mechanisms of liver tolerance. Immunol. Rev. 213: 101-118.
4. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
5. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
6. Racanelli, V., and B. Rehermann. 2006. The liver as an immunological organ. Hepatology. 43 (Suppl.): 54-62.
7. Brutkiewicz, R. R. 2006. CD1d ligands: the good, the bad, and the ugly. J. Immunol. 177: 769-775.
8. Zigmond, E., S. Preston, O. Pappo, G. Lalazar, M. Margalit, Z. Shalev, L. Zolotarov, D. Friedman, R. Alper, and Y. Ilan. 2007. Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Gut. 56: 82-89.
9. Shibolet, O., R. Alper, L. Zlotogarov, B. Thalenfeld, D. Engelhardt, E. Rabbani, and Y. Ilan. 2003. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigenpulsed dendritic cells. Int. J. Cancer. 106: 236-243.
10. Shibolet, O., R. Alper, L. Zolotarov, S. Trop, B. Thalenfeld, D. Engelhardt, E. Rabbani, and Y. Ilan. 2004. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Clin. Immunol. 111: 82-92.
11. Stanic, A. K., J. J. Park, and S. Joyce. 2003. Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences. Immunology. 109: 171-184.
12. Tsuji, M. 2006. Glycolipids and phospholipids as natural CD1dbinding NKT cell ligands. Cell. Mol. Life Sci. 63: 1889-1898.
13. Van Kaer, L. 2005. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5: 31-42.
14. Zhou, D., J. Mattner, C. Cantu 3rd, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science. 306: 1786-1789.
15. Zhou, D. 2006. The immunological function of iGb3. Curr. Protein Pept. Sci. 7: 325-333.
16. Porubsky, S., A. O. Speak, B. Luckow, V. Cerundolo, F. M. Platt, and H. J. Grone. 2007. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA. 104: 5977-5982.
17. Sriram, V., W. Du, J. Gervay-Hague, and R. R. Brutkiewicz. 2005. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1dspecific ligands for NKT cells. Eur. J. Immunol. 35: 1692-1701.
18. Brutkiewicz, R. R., Y. Lin, S. Cho, Y. K. Hwang, V. Sriram, and T. J. Roberts. 2003. CD1d-mediated antigen presentation to natural killer T (NKT) cells. Crit. Rev. Immunol. 23: 403-419.
19. Stanic, A. K., A. D. De Silva, J. J. Park, V. Sriram, S. Ichikawa, Y. Hirabyashi, K. Hayakawa, L. Van Kaer, R. R. Brutkiewicz, and S. Joyce. 2003. Defective presentation of the CD1d1-restricted natural Va14Ja18NKTlymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency. Proc. Natl. Acad. Sci. USA. 100: 1849-1854.
20. Ortaldo, J. R., H. A. Young, R. T. Winkler-Pickett, E. W. Bere, Jr., W. J. Murphy, and R. H. Wiltrout. 2004. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J. Immunol. 172: 943-953.
21. Margalit, M., S. A. Ghazala, R. Alper, E. Elinav, A. Klein, V. Doviner, Y. Sherman, B. Thalenfeld, D. Engelhardt, E. Rabbani, et al. 2005. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G917-G925.
22. Margalit, M., Z. Shalev, O. Pappo, M. Sklair-Levy, R. Alper, M. Gomori, D. Engelhardt, E. Rabbani, and Y. Ilan. 2006. Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice. J. Pharmacol. Exp. Ther. 319: 105-110.
23. Helms, J. B., and C. Zurzolo. 2004. Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic. 5: 247-254.
24. Anderson, H. A., E. M. Hiltbold, and P. A. Roche. 2000. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1: 156-162.
25. Brown, D. A., and E. London. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275: 17221-17224.
26. Park, Y. K., J. W. Lee, Y. G. Ko, S. Hong, and S. H. Park. 2005. Lipid rafts are required for efficient signal transduction by CD1d. Biochem. Biophys. Res. Commun. 327: 1143-1154.
27. Yu, K. O., J. S. Im, A. Molano, Y. Dutronc, P. A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, et al. 2005. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc. Natl. Acad. Sci. USA. 102: 3383-3388.
28. Ilan, Y., S. Weksler-Zangen, S. Ben-Horin, J. Diment, B. Sauter, E. Rabbani, D. Engelhardt, N. R. Chowdhury, J. R. Chowdhury, and E. Goldin. 2000. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am. J. Gastroenterol. 95: 966-973.
29. Trop, S., D. Samsonov, I. Gotsman, R. Alper, J. Diment, and Y. Ilan. 1999. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model. Hepatology. 29: 746-755.
30. Rouvinski, A., I. Gahali-Sass, I. Stav, E. Metzer, H. Atlan, and A. Taraboulos. 2003. Both raft- and non-raft proteins associate with CHAPS-insoluble complexes: some APP in large complexes. Biochem. Biophys. Res. Commun. 308: 750-758.
31. Samsonov, D., R. Alper, and Y. Ilan. 2001. Pregnancy rate and embryo loss in the NK1.1+ T cell-depleted mouse. J. Reprod. Med. 46: 54-60.
32. Hammond, K. J., and D. I. Godfrey. 2002. NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens. 59: 353-363.
33. Renno, T., M. Hahne, J. Tschopp, and H. R. MacDonald. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 183: 431-437.
34. Bonfoco, E., P. M. Stuart, T. Brunner, T. Lin, T. S. Griffith, Y. Gao, H. Nakajima, P. A. Henkart, T. A. Ferguson, and D. R. Green. 1998. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity. 9: 711-720.
35. Thomas, S., A. Preda-Pais, S. Casares, and T. D. Brumeanu. 2004. Analysis of lipid rafts in T cells. Mol. Immunol. 41: 399-409.
36. Balamuth, F., D. Leitenberg, J. Unternaehrer, I. Mellman, and K. Bottomly. 2001. Distinct patterns of membrane microdomain partitioning in Th1 and th2 cells. Immunity. 15: 729-738.
37. Badizadegan, K., H. E. Wheeler, Y. Fujinaga, and W. I. Lencer. 2004. Trafficking of cholera toxin-ganglioside GM1 complex into Golgi and induction of toxicity depend on actin cytoskeleton. Am. J. Physiol. 287: C1453-C1462.
38. Simons, M., T. Friedrichson, J. B. Schulz, M. Pitto, M. Masserini, and T. V. Kurzchalia. 1999. Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol. Biol. Cell. 10: 3187-3196.
39. Janes, P. W., S. C. Ley, and A. I. Magee. 1999. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147: 447-461.
40. Rodgers, W., B. Crise, and J. K. Rose. 1994. Signals determining protein tyrosine kinase and glycosyl-phosphatidylinositol-anchored protein targeting to a glycolipid-enriched membrane fraction. Mol. Cell. Biol. 14: 5384-5391.
41. Krishnan, S., M. P. Nambiar, V. G. Warke, C. U. Fisher, J. Mitchell, N. Delaney, and G. C. Tsokos. 2004. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J. Immunol. 172: 7821-7831.
42. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.